TY - JOUR
TI - Binimetinib plus encorafenib for metastatic melanoma
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2019
ET - 2019/09/13
VL - 42
IS - 5
SP - 168
EP - 169
DO - 10.18773/austprescr.2019.057
LA - eng
UR - https://australianprescriber.tg.org.au/articles/binimetinib-plus-encorafenib-for-metastatic-melanoma.html
KW - Mektovi
KW - Braftovi
KW - metastatic melanoma
KW - binimetinib
KW - encorafenib
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -